The increase of effector CD8: naïve CD8 ratio and Th1, Th2, and Th17 cell differentiation signaling pathways were also enriched in T cells of ASS-ILD patients suggesting their roles in ILD development. This evidence concerns the gene CD8A and interstitial lung disease.